Trump, accustomed to treating baldness, saves the lives of thousands of men

WASHINGTON (Reuters) – Finasteride, a drug used to fight baldness in men, may reduce the risk of prostate cancer, researchers at the University of Texas at the Medical Center found. University of Texas. The drug used by US President Donald Trump to combat baldness can offer a safe and inexpensive option to protect men from this deadly disease, Sun newspaper reported.

The researchers have now discovered that the drug, marketed under the brand name Propecia, could give hope to thousands of men, protecting it from 25% against the risk of prostate cancer.

"Finasteride is safe, inexpensive and effective as a preventative strategy against prostate cancer," said Dr. Ian Thompson, who participated in the study. The experiment, which began 25 years ago, involved about 20,000 men, making it one of the largest prostate cancer trials ever conducted.

According to findings published in the New England Journal, fewer than 100 men who participated in the prostate cancer prevention trial died. Dr. Thompson said that doctors should inform patients of the benefits of this drug, especially those who undergo regular screening tests for prostate specific antigen (PSA).

The research team emphasizes that prostate cancer prevention will have a major impact on public health, especially as the diagnosis of the prostate is made. "This may not sound like a" quick fix ", as many hope.